CEA, TPA, CA 19-9, SCC and CYFRA at diagnosis and in the follow-up of anal canal tumors

International Surgery

Volumn 82, Issue 3, 1997, Pages 275-279

  Indinnimeo, M ^a   Reale, M G ^a   Cicchini, C ^a   Stazi, A ^a   Fiori, E ^a   Izzo, P ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anal canal neoplasms; CA19 9; CEA; CYFRA; Diagnosis; Follow up; Recurrence; SCC; TPA

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN 19 FRAGMENT; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ANUS TUMOR; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLOACA; FEMALE; FOLLOW UP; HUMAN; MALE;

AGED; ANTIGENS, NEOPLASM; ANUS NEOPLASMS; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; FEMALE; FOLLOW-UP STUDIES; HUMANS; KERATINS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; SERPINS; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0030773685     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965;122:467-481.
2. NIH Consensus Statement. Carcinoembryonic antigen: Its role as a marker in the management of cancer. Cancer Res 1981;41: 2017-2018.
3. Tanum G, Stenwig AE, Bormer O, Tveit KM. Carcinoembryonic antigen in anal carcinoma. Acta Oncol 1992;31(3):333-335.
4. Willet CG, Daly WJ, Warshaw AL. CA19-9 is an index of response to neoadjunctive chemoradiation therapy in pancreatic cancer. Am J Surg 1996;172(4):350-352.
5. Kornek G, Schenkt T, Raderer M, Djavarmad M, Scheithauer W. Tissue polypeptide specific antigen in monitoring palliative treatment response of patients with gastrointestinal tumors. Br J Cancer 1995;7(1):182-185.
6. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628.
7. Kato H, Morioka H, Tsutsui H, Aramaki S, Torigoe T. Value of tumor-antigen TA4 of squamous cell carcinoma in predicting the extent of cervical cancer. Cancer 1982;50:1294-1296.
8. Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M. Tumor associated antigen TA4 in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Cancer 1985; 56:302-308.
9. Yagi H, Danno K, Maruguchi Y, Yamamoto M, Inamura I. Significance of squamous cell carcinoma (SCC)-related antigens in cutaneous SCC. Arch Dermatol 1987;123:902-906.
10. Petrelli NJ, Palmer M, Herrera L, Bhargava A. The utility of squamous cell carcinoma antigen for the follow-up of patients with squamous cell carcinoma of the anal canal. Cancer 1992;70(1):35-9.
11. Yamanaka N, Himi T, Harabuchi Y, Hoki K, Kataura A. Soluble immune complexes and squamous cell carcinoma-related antigens in patients with head and neck cancer. Cancer 1988;62:1932-1938.
12. Mino N, Iio A, Hamamoto K. Availability of tumor antigen 4 as a marker of squamous cell carcinoma of the lung and other organs. Cancer 1988;62:730-734.
13. Burtin P, Bonali A, Boyer J, Daver A, Larra F, Ronceray J. Diagnostic and prognostic value of serum levels of SCC antigen in patients with esophageal epidermoid carcinomas: a retrospective study in 64 patients. In: Kato H, Ebert W, Herberman RB, Johnson J, editors. SCC-antigen in the management of squamous cell carcinoma. Princeton, NJ: Excerpta Medica, 1987:142-148.
14. Fontana X, Lagrange JL, Francois E, Bourry J, Chauvel P, Sordage M et al. Assessment of "Squamous Cell Carcinoma Antigen" (SCC) as a marker of epidermoid carcinoma of the anal canal. Dis Colon Rectum 1991;34(2):126-131.
15. Moll R, Franke WW, Shiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
16. Pujol JL, Grenier J, Duares JP, Daver A, Pujol H, Michel FB. Serum fragments of cytokeratin subunit 19 measured by CYFRA 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 1993;53:1-6.
17. Weber K, Osborn M, Moll R, Wilklund B, Luning B. Tissue polypeptide antigen (TPA) is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: re-evaluation of a human tumor marker. EMBO J 1984;3:2707-2014.
18. Barak M, Steiner M, Finkel B, Abrahamson J, Antal S, Gruener N. CA15.3, TPA, and MCA as markers for breast cancer. Eur J Cancer 1990;26:577-580.
19. Maffei S, Rudoni M, Antonini G, Sacchetti G, Krengli M. CA15-3 associated with CEA and TPA in the follow-up of breast carcinoma. Minerva Med 1990;81:759-763.
20. Abbasciano V, Levato F, Zavagli G. Specificity of carcinoembryonic antigen, gastrointestinal cancer-associated antigen, tissue polypeptide antigen, fibrinopeptide A and gamma-glutamyltransferase in the diagnosis and follow-up of gastric cancer. Oncology 1988;45:159-161.
21. Barillari P, D'Angelo F, Ramacciato G, Ricci M, Santeusanio G, De Angelis R et al. The role of CEA, TPA and CA19-9 in the early detection of recurrent gastric cancer. Cancer J 1990;3:139-142.
22. Stahle E, Glimelius B, Bergstrom R, Pahlman L. Preoperative prediction of late cancer-specific deaths in patients with rectal and rectosigmoid carcinoma. Int J Colon Dis 1989;4:182-187.
23. Gronowitz JS, Bergstrom R, Nou E, Pahlman S, Brodin O, Nilsson S et al. Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis. Cancer 1990;66:722-732.
24. Tizzani A, Casetta G, Cavallini A, Piana P, Piantino P. Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma. Minerva Urol Nefrol 1990; 42:69-71.
25. Lewenhaupt A, Ekman P, Eneroth P, Nilsson B, Nordstrom L. Tissue polypeptide antigen (TPA) as a prognostic aid in human prostatic carcinoma. Prostate 1985;6:285-291.
26. Panza N, Pacilio G, Campanella L, Peluso G, Battista C, Amoriello A et al. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma. Cancer 1988;61:76-83.